3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Odontogenic Cysts
2
Lung Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Nose Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esthesioneuroblastoma, Olfactory
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
olaparib
4
Pluvicto
4
Abiraterone Acetate
3
testosterone 17 beta-cypionate
2
radium Ra 223 dichloride
2
enzalutamide
2
darolutamide
2
Prednisone
2
Prednisolone
2
Docetaxel
2
Androgen Antagonists
2
sipuleucel-T
1
lactitol
1
fludarabine phosphate
1
fludarabine
1
fluciclovine F-18
1
enfortumab vedotin
1
cabozantinib
1
cabazitaxel
1
alovudine
1
abiraterone
1
Standard of Care
1
Radium-223
1
PSMA-617
1
Nivolumab
1
Gonadotropin-Releasing Hormone
1
Cyclophosphamide
1
Bortezomib
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Metastatic Castration-resistant Prostate Cancer
×
Radionuclide Imaging
×
1 year
×
Clear all
No trials found.